Drug profile · INN
acebutolol hydrochloride
ACEBUTOLOL HYDROCHLORIDE
acebutolol hydrochloride (ACEBUTOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — acebutolol hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 6
- Programs
- 0
- Data quality
- 0.89
Quick answer
acebutolol hydrochloride (ACEBUTOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-1 adrenergic receptor antagonist
Primary target: Beta-1 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Related patents
-
US 11439585
Programmable pharmaceutical compositions for chrono drug release
granted -
US 11166906
Programmable pharmaceutical compositions for chrono drug release
granted -
US 11154494
Programmable pharmaceutical compositions for chrono drug release
granted -
US 10052467
Applicator for applying a fluid to a surface
granted -
US 9629805
Stabilization of moisture-sensitive drugs
granted -
US 9227044
Applicator for applying a fluid to a surface
granted
Frequently asked questions
What is acebutolol hydrochloride?
acebutolol hydrochloride (ACEBUTOLOL HYDROCHLORIDE) is a beta-1 adrenergic receptor antagonist. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for acebutolol hydrochloride?
ACEBUTOLOL HYDROCHLORIDE is a marketed brand name for acebutolol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of acebutolol hydrochloride?
acebutolol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.